Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:09:53 +0200Fri, 17 May 2024 15:37:00 +0200Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation: 28/03/2019, Revision: 11, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ajovyHuman medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation: 28/03/2019, Revision: 11, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ajovyFri, 17 May 2024 15:37:00 +0200Human medicineAjovy : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4833-en.pdfAjovy : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4833-en.pdfMon, 20 Nov 2023 11:30:00 +0100Human medicine